Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pemphigus-like hypereosinophilic syndrome with FIP1L1-PDGFRA fusion gene: A challenging and uncommon clinical presentation.
|
31021002 |
2019 |
Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.
|
28885361 |
2017 |
Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.
|
26257279 |
2016 |
Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The purpose of this review is to provide an overview of the differential diagnosis for eosinophilia, to recommend specific steps for the pathologist evaluating blood and bone marrow, and to emphasize 2 important causes of eosinophilia that require specific ancillary tests for diagnosis: myeloproliferative neoplasm with PDGFRA rearrangement and lymphocyte-variant hypereosinophilic syndrome.
|
27684977 |
2016 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.
|
26797802 |
2016 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.
|
23337549 |
2014 |
Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.
|
21224473 |
2011 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
A 35-year-old man with FIP1L1-PDGFRA positive hypereosinophilic syndrome and cardiac involvement, was treated with imatinib 100 mg daily.
|
17544504 |
2008 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interstitial deletion involving chromosome 4q12 generates the novel tyrosine kinase fusion protein encoded by FIP1L1-PDGFRA, which is present in many patients previously labelled as having hypereosinophilic syndrome, initially reported in 2003.
|
18256119 |
2008 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.
|
18344568 |
2008 |
Disseminated eosinophilic collagen disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The fusion protein between the platelet-derived growth factor receptor alpha (PDGFRalpha, P) gene and the Fip1-like1 (FIP1L1, F) may be identified in 14 to 60% of HES and it indicates a clonal hypereosinophilic syndrome called F/P-positive CEL.
|
17549478 |
2008 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.
|
16965435 |
2006 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome.
|
16409293 |
2006 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
|
15921374 |
2005 |
Disseminated eosinophilic collagen disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The discovery of the FIP1L1-PDGFRA fusion gene in the hypereosinophilic syndrome is an example of the power of clinical translational research and identifies interstitial chromosomal deletion as a novel mechanism to generate oncogenic tyrosine kinase fusion genes.
|
14676627 |
2004 |